Safety, tolerability, and efficacy of pegylated-interferon alfa-2a plus ribavirin in HCV-related decompensated cirrhotics
Articles > Article · 2008
Authors: Fatih TEKİN, Fulya GÜNŞAR, Abdullah Zeki KARASU, Ulus Salih AKARCA, Galip ERSÖZ
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Journal Indexed in SCI Expanded, International, 2008, vol 27, pp 1081-1085
DOI: 10.1111/j.1365-2036.2008.03680.x
Summary
Background